Gastrointestinal Stromal Tumors (GIST) Novartis Oncology
Email This PagePrint This Page

Find a Glivec Blood Level Testing Lab

Gastrointestinal Stromal Tumors (GIST)
Gastrointestinal Stromal Tumors (GIST)
Search:
Leading Expert Video Image-Literature Update Series
GIST Alliance: Find a Glivec Blood Level Testing Lab for Your Patients

GIST ALLIANCE provides easy access to GLIVEC blood level testing labs

Glivec blood level testing will help identify patients that may have a lower probability of achieving an optimal outcome.

GLIVEC plasma trough levels above 1100 ng/mL have been shown to correlate with significantly better clinical outcomes1,2

Blood level testing for patients with GIST may help optimize clinical benefit from GLIVEC1,2
 
North America Europe Asia Australia
 
USA
www.gistalliance.com
Europe
click here
China
click here
Australia
www.gistalliance.com.au
 
Canada
click here
Middle East & Africa Hong Kong
click here
 
 
South America Jordan
click here
Thailand
click here
 
 
Argentina
click here
Isreal
click here
Singapore
click here
 
 
  South Africa
click here
Taiwan
click here
 
 
  Turkey
click here
South Korea
click here
 
 

References:

1.
Demetri GD, Wang Y, Wehrle E, Blanke C, Joensuu H, von Mehren M. Correlation of imatinib plasma levels with clinical benefit in patients (Pts) with unresectable/metastatic gastrointestinal stromal tumors (GIST). Presented at: ASCO Gastrointestinal Cancers Symposium; January 25-27, 2008; Orlando, FL. Abstract 3 and Slides.
2.
von Mehren M, Wang Y, Joensuu H, Blanke CD, Wehrle E, Demetri GD. Imatinib pharmacokinetics (PK) and its correlation with clinical response in patients with unresectable/metastatic gastrointestinal stromal tumor (GIST). J Clin Oncol. 2008;26(suppl):Abstract 4523.